KDA Group Inc. (CVE:KDA) Insider Sells C$53,850.00 in Stock

KDA Group Inc. (CVE:KDA) insider Tenshi Life Sciences Pte. Limited sold 179,500 shares of the business’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of C$0.30, for a total transaction of C$53,850.00.

Tenshi Life Sciences Pte. Limited also recently made the following trade(s):

• On Friday, October 11th, Tenshi Life Sciences Pte. Limited sold 3,000 shares of KDA Group stock. The stock was sold at an average price of C$0.30, for a total transaction of C$900.00.
• On Monday, October 7th, Tenshi Life Sciences Pte. Limited sold 74,000 shares of KDA Group stock. The shares were sold at an average price of C$0.30, for a total transaction of C$22,200.00.
• On Friday, October 4th, Tenshi Life Sciences Pte. Limited sold 48,500 shares of KDA Group stock. The shares were sold at an average price of C$0.30, for a total value of C$14,550.00.
• On Monday, September 30th, Tenshi Life Sciences Pte. Limited sold 153,500 shares of KDA Group stock. The stock was sold at an average price of C$0.30, for a total value of C$46,050.00.
• On Wednesday, September 25th, Tenshi Life Sciences Pte. Limited sold 77,000 shares of KDA Group stock. The shares were sold at an average price of C$0.30, for a total value of C$23,100.00.
• On Monday, September 23rd, Tenshi Life Sciences Pte. Limited sold 43,500 shares of KDA Group stock. The shares were sold at an average price of C$0.30, for a total transaction of C$13,050.00.

KDA Group Price Performance

CVE:KDA opened at C$0.29 on Thursday. The company has a market capitalization of C$50.87 million, a price-to-earnings ratio of -7.50 and a beta of 1.24. The company has a 50-day moving average of C$0.25 and a 200-day moving average of C$0.27. KDA Group Inc. has a 52 week low of C$0.14 and a 52 week high of C$0.66. The company has a debt-to-equity ratio of 7.36, a quick ratio of 0.35 and a current ratio of 2.10.

KDA Group Company Profile

KDA Group Inc, together with its subsidiaries, provides solutions and services to pharmacies and pharmaceutical companies in Canada. The company operates through three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. It provides pharmacy staff replacement services, professional and continued medical training services, pharmacy re-engineering services, and pharmaceutical training services.